Literature DB >> 16177331

Role of NADase in virulence in experimental invasive group A streptococcal infection.

Angela L Bricker1, Vincent J Carey, Michael R Wessels.   

Abstract

Group A streptococci (GAS) produce several exoproteins that are thought to contribute to the pathogenesis of human infection. Two such proteins, streptolysin O (SLO) and NAD(+)-glycohydrolase (NADase), have been shown to interact functionally as a compound signaling toxin. When GAS are bound to the surface of epithelial cells in vitro, SLO forms pores in the cell membrane and delivers NADase to the epithelial cell cytoplasm. In vitro, intoxication of keratinocytes with NADase is associated with cytotoxic effects and induction of apoptosis; however, the importance of NADase during infection of an animal host has not been established. We employed isogenic GAS mutants to assess the contribution of NADase activity to GAS virulence in vivo using mouse models of invasive soft-tissue infection and septicemia. In both models, mutant GAS that lacked NADase activity were significantly attenuated for virulence compared with the isogenic wild-type parent, confirming an important role for NADase in the infection of a host animal. A double mutant lacking SLO and NADase activity had an intermediate virulence phenotype, consistent with the hypothesis that SLO evokes a protective innate immune response. We conclude that NADase and SLO together enhance GAS virulence in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177331      PMCID: PMC1230891          DOI: 10.1128/IAI.73.10.6562-6566.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

Review 1.  The family of thiol-activated, cholesterol-binding cytolysins.

Authors:  M Palmer
Journal:  Toxicon       Date:  2001-11       Impact factor: 3.033

2.  A comparison of group A streptococci from invasive and uncomplicated infections: are virulent clones responsible for serious streptococcal infections?

Authors:  Dwight R Johnson; Jason T Wotton; Anita Shet; Edward L Kaplan
Journal:  J Infect Dis       Date:  2002-05-17       Impact factor: 5.226

3.  Molecular epidemiology of nga and NAD glycohydrolase/ADP-ribosyltransferase activity among Streptococcus pyogenes causing streptococcal toxic shock syndrome.

Authors:  D L Stevens; D B Salmi; E R McIndoo; A E Bryant
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

4.  Diffusion-in-gel methods for immunological analysis.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1958

5.  Cytolysin-mediated translocation (CMT): a functional equivalent of type III secretion in gram-positive bacteria.

Authors:  J C Madden; N Ruiz; M Caparon
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

6.  NAD+-glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci.

Authors:  Angela L Bricker; Colette Cywes; Cameron D Ashbaugh; Michael R Wessels
Journal:  Mol Microbiol       Date:  2002-04       Impact factor: 3.501

7.  Role of streptolysin O in a mouse model of invasive group A streptococcal disease.

Authors:  B Limbago; V Penumalli; B Weinrick; J R Scott
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

8.  Cytotoxic effects of streptolysin o and streptolysin s enhance the virulence of poorly encapsulated group a streptococci.

Authors:  Gabriele Sierig; Colette Cywes; Michael R Wessels; Cameron D Ashbaugh
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta.

Authors:  B Schwartz; A Schuchat; M J Oxtoby; S L Cochi; A Hightower; C V Broome
Journal:  JAMA       Date:  1991-08-28       Impact factor: 56.272

10.  NAD-glycohydrolase production and speA and speC distribution in Group A streptococcus (GAS) isolates do not correlate with severe GAS diseases in the Australian population.

Authors:  Armando DelVecchio; Michael Maley; Bart J Currie; K S Sriprakash
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

View more
  34 in total

1.  Streptococcus pyogenes cytolysin-mediated translocation does not require pore formation by streptolysin O.

Authors:  N'Goundo Magassa; Sukantha Chandrasekaran; Michael G Caparon
Journal:  EMBO Rep       Date:  2010-03-26       Impact factor: 8.807

Review 2.  CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity.

Authors:  Fabio Malavasi; Silvia Deaglio; Enza Ferrero; Ada Funaro; Jaime Sancho; Clara M Ausiello; Erika Ortolan; Tiziana Vaisitti; Mercedes Zubiaur; Giorgio Fedele; Semra Aydin; Elena V Tibaldi; Ilaria Durelli; Riccardo Lusso; Franco Cozno; Alberto L Horenstein
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

Review 3.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

4.  Characterization of Streptococcus pyogenes beta-NAD+ glycohydrolase: re-evaluation of enzymatic properties associated with pathogenesis.

Authors:  Joydeep Ghosh; Patricia J Anderson; Sukantha Chandrasekaran; Michael G Caparon
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

5.  The Rgg regulator of Streptococcus pyogenes influences utilization of nonglucose carbohydrates, prophage induction, and expression of the NAD-glycohydrolase virulence operon.

Authors:  Alexander V Dmitriev; Emily J McDowell; Kyle V Kappeler; Michelle A Chaussee; Lindsey D Rieck; Michael S Chaussee
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

6.  Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences.

Authors:  Waleed Nasser; Stephen B Beres; Randall J Olsen; Melissa A Dean; Kelsey A Rice; S Wesley Long; Karl G Kristinsson; Magnus Gottfredsson; Jaana Vuopio; Kati Raisanen; Dominique A Caugant; Martin Steinbakk; Donald E Low; Allison McGeer; Jessica Darenberg; Birgitta Henriques-Normark; Chris A Van Beneden; Steen Hoffmann; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

Review 7.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates.

Authors:  Tadayoshi Ikebe; Manabu Ato; Takayuki Matsumura; Hideki Hasegawa; Tetsutaro Sata; Kazuo Kobayashi; Haruo Watanabe
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

9.  NADase as a target molecule of in vivo suppression of the toxicity in the invasive M-1 group A Streptococcal isolates.

Authors:  Ichiro Tatsuno; Masanori Isaka; Masaaki Minami; Tadao Hasegawa
Journal:  BMC Microbiol       Date:  2010-05-17       Impact factor: 3.605

10.  A molecular trigger for intercontinental epidemics of group A Streptococcus.

Authors:  Luchang Zhu; Randall J Olsen; Waleed Nasser; Stephen B Beres; Jaana Vuopio; Karl G Kristinsson; Magnus Gottfredsson; Adeline R Porter; Frank R DeLeo; James M Musser
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.